Leading broker downgrades InvoCare Limited shares to a sell

The InvoCare Limited (ASX:IVC) share price could be on its way to $16.10 according to one leading broker…

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

In afternoon trade the InvoCare Limited (ASX: IVC) share price is 1% lower to $17.05.

But as far as one leading broker is concerned its shares could continue to tumble further over the coming months.

According to a note out of UBS, the investment bank has downgraded the funeral company to a sell rating from neutral.

The broker has, however, raised its price target from $14.70 to $16.10. This is approximately 5.5% lower than the current share price.

UBS has made this move on valuation grounds, which isn't at all surprising in my opinion.

After all, the investment bank estimates that InvoCare will deliver earnings per share of 54 cents in FY 2017 and then 56 cents in FY 2018.

This means that InvoCare's shares are changing hands at 30x estimated FY 2018 earnings. This is a considerable premium given its current growth rate.

Should you sell?

While I think InvoCare is a quality business and deserves to trade at a premium due to its defensive nature, I don't think it warrants a multiple of 30x forward earnings.

In light of this, I would agree with UBS that the funeral company is a sell today.

The same could be said for rival Propel Funeral Partners Ltd (ASX: PFP). Although I suspect it is capable of growing at a quicker rate due to its smaller size, its shares have rallied strongly since their IPO last month and look fully valued now.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

A white and black robot in the form of a human being stands in front of a green graphic holding a laptop and discussing robotics and automation ASX shares
Technology Shares

Joining the revolution: How I'd invest in ASX AI shares right now

Advances in artificial intelligence (AI) could usher in a new industrial revolution. Here’s how you can invest in it.

Read more »

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »